Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation.

08/08/2018
/ Publications
/
IMRT
Chemotherapy

This MD Anderson study compared IMRT and PBT chemoradiation for esophageal cancer. Patients who had IMRT and PBT matched by propensity score (n = 220) were not...

Potential Morbidity Reduction with Proton Radiation Therapy for Breast Cancer.

04/04/2018
/ Publications
/
Dosimetry
Chemotherapy

A systematic review by MSKCC about the increasing emphasis on the mitigation of iatrogenic morbidity, with particular attention to heart and lung exposure in...

Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer.

11/12/2017
/ Publications
/
Chemotherapy

Compared the relative risk of radiation-induced lymphopenia between IMRT and PBT in esophageal cancer (EC) patients undergoing neoadjuvant chemoradiation...

Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma (EC).

11/06/2017
/ Publications
/
IMPT
Chemotherapy
Toxicity

19 patients with EC treated with IMPT concurrently with chemotherapy. Clinical complete response was achieved in 84%.

The most common grade 3 acute toxicities...

How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis

11/02/2016
/ Publications
/
Chemotherapy
PT101

Published in the Green Journal, this ESTRO-HERO (Health Economics in Radiation Oncology) analysis reported about 4 millions new cancer patients are predicted in...

PRONTOX – a randomized control trial.

10/11/2016
/ Publications
/
Chemotherapy

Although radiochemotherapy with photons is the standard treatment for now for locally advanced NSCLC, but acute radiation-induced toxicity such as esophagitis...

Impact of lymphopenia on the clinical outcomes of esophageal cancer patients

28/10/2021
/ Publications
/
Chemotherapy

A study by the Tsukuba group, Japan. This study retrospectively reviewed 69 patients with esophageal cancer treated with XRT (n=15) and PBT (n= 54) and...

PBRT associated with a lower opioid pain requirement and a lower rate of gastrostomy tube dependence

02/02/2016
/ Publications
/
Chemotherapy
IMRT
Chemotherapy

A matched analysis compared PBRT and IMRT for nasopharynx and paranasal sinus cancers with concurrent chemotherapy, reported that PBRT was associated with a...

Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer.

11/11/2021
/ Publications
/
Chemotherapy

This study reported outcomes of 25 patients with limited-stage small cell lung cancer treated with combined proton and carbon-ion radiotherapy. Proton and...

Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report.

07/02/2022
/ Publications
/
Chemotherapy

A group of researchers from Japan reported a rare case of oligorecurrent esophageal cancer in complete remission for 5 years after a course of definitive proton...